SAP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into SAP SE and Encourages Investors to Contact the Firm
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SAP SE (“SAP” or “the Company”) (NYSE: SAP). Investors who purchased SAP securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SAP.
Investigation Details
On September 25, 2024, Bloomberg News reported that the U.S. Department of Justice was investigating SAP and other companies for potentially conspiring to overcharge U.S. government agencies over the course of a decade, by “fix[ing] prices on sales to the U.S. military and other parts of the government”. On this news, SAP’s American depositary receipt (“ADR”) price fell $7.64 per ADR, or 3.31%, to close at $223.29 per ADR on September 25, 2024.
What's Next?
If you are aware of any facts relating to this investigation or purchased SAP securities, you can assist this investigation by visiting the firm’s site: bgandg.com/SAP. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks